Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children a...
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
About this item
Full title
Author / Creator
Mauz-Körholz, Christine, Prof , Landman-Parker, Judith, Prof , Balwierz, Walentyna, Prof , Ammann, Roland A, Prof , Anderson, Richard A, Prof , Attarbaschi, Andische, MD , Bartelt, Jörg M, MD , Beishuizen, Auke, MD , Boudjemaa, Sabah, MD , Cepelova, Michaela, MD , Claviez, Alexander, Prof , Daw, Stephen, MD , Dieckmann, Karin, Prof , Fernández-Teijeiro, Ana, Prof , Fosså, Alexander, MD , Gattenlöhner, Stefan, Prof , Georgi, Thomas, MD , Hjalgrim, Lisa L, MD , Hraskova, Andrea, MD , Karlén, Jonas, MD , Kluge, Regine, Prof , Kurch, Lars, MD , Leblanc, Thiery, MD , Mann, Georg, Prof , Montravers, Francoise, Prof , Pears, Jean, MD , Pelz, Tanja, MD , Rajić, Vladan, Prof , Ramsay, Alan D, MD , Stoevesandt, Dietrich, MD , Uyttebroeck, Anne, Prof , Vordermark, Dirk, Prof , Körholz, Dieter, Prof , Hasenclever, Dirk, PhD and Wallace, William Hamish, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundChildren and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and radiotherapy, but lo...
Alternative Titles
Full title
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Landman-Parker, Judith, Prof
Balwierz, Walentyna, Prof
Ammann, Roland A, Prof
Anderson, Richard A, Prof
Attarbaschi, Andische, MD
Bartelt, Jörg M, MD
Beishuizen, Auke, MD
Boudjemaa, Sabah, MD
Cepelova, Michaela, MD
Claviez, Alexander, Prof
Daw, Stephen, MD
Dieckmann, Karin, Prof
Fernández-Teijeiro, Ana, Prof
Fosså, Alexander, MD
Gattenlöhner, Stefan, Prof
Georgi, Thomas, MD
Hjalgrim, Lisa L, MD
Hraskova, Andrea, MD
Karlén, Jonas, MD
Kluge, Regine, Prof
Kurch, Lars, MD
Leblanc, Thiery, MD
Mann, Georg, Prof
Montravers, Francoise, Prof
Pears, Jean, MD
Pelz, Tanja, MD
Rajić, Vladan, Prof
Ramsay, Alan D, MD
Stoevesandt, Dietrich, MD
Uyttebroeck, Anne, Prof
Vordermark, Dirk, Prof
Körholz, Dieter, Prof
Hasenclever, Dirk, PhD
Wallace, William Hamish, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8716340
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8716340
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(21)00470-8
